Faculty Opinions recommendation of High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites.

Author(s):  
Won Seog Kim
Blood ◽  
2019 ◽  
Vol 134 (12) ◽  
pp. 946-950 ◽  
Author(s):  
Suraya Elfrink ◽  
Charlotte M. de Winde ◽  
Michiel van den Brand ◽  
Madeleine Berendsen ◽  
Margaretha G. M. Roemer ◽  
...  

Key Points Loss-of-function mutations in CD37 occur predominantly in diffuse large B-cell lymphoma at immune-privileged sites. CD37-mutated lymphoma B cells show impaired CD37 cell-surface localization, which may have implications for anti-CD37 therapies.


Cancer ◽  
2011 ◽  
Vol 117 (19) ◽  
pp. 4512-4521 ◽  
Author(s):  
Kosei Matsue ◽  
Brian Y. Hayama ◽  
Kan-Ichi Iwama ◽  
Takafumi Koyama ◽  
Hideaki Fujiwara ◽  
...  

2017 ◽  
Vol 89 (7) ◽  
pp. 85-92 ◽  
Author(s):  
N G Gabeeva ◽  
D A Koroleva ◽  
A V Belyaeva ◽  
N G Chernova ◽  
L A Kuzmina ◽  
...  

Double-hit lymphoma (DHL) is a rare aggressive B-cell lymphoma with concomitant c-MYC, BCL2 or BCL6 gene rearrangements, which is characterized by the high frequency of extranodal lesions and by resistance to chemotherapy. The median survival does not exceed 18 months in patients with this disease. The majority of DHL is represented by с-MYC/BCL2 cases. The combination of c-MYC/BCL6 occurs rarely (5—8%). The paper describes a case of DHL with concomitant c-MYC and BCL6 gene rearrangements, which mimics diffuse large B-cell lymphoma, leg-type.


2014 ◽  
Vol 150 (11) ◽  
pp. 1173 ◽  
Author(s):  
Anne Pham-Ledard ◽  
Marie Beylot-Barry ◽  
Coralie Barbe ◽  
Marion Leduc ◽  
Tony Petrella ◽  
...  

2011 ◽  
Vol 89 (5) ◽  
pp. 493-504 ◽  
Author(s):  
Marzia Ognibene ◽  
Ottavia Barbieri ◽  
Cristina Vanni ◽  
Luca Mastracci ◽  
Simonetta Astigiano ◽  
...  

2016 ◽  
Vol 25 (2) ◽  
pp. 118-126 ◽  
Author(s):  
Jianchao Wang ◽  
Wenshuang Ding ◽  
Limin Gao ◽  
Wenqing Yao ◽  
Min Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document